1. Home
  2. MAXN vs ANL Comparison

MAXN vs ANL Comparison

Compare MAXN & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$3.00

Market Cap

45.2M

Sector

Technology

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$1.05

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAXN
ANL
Founded
2019
2004
Country
Singapore
Cayman Islands
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
52.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MAXN
ANL
Price
$3.00
$1.05
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
75.9K
13.6K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$176,414,000.00
N/A
Revenue This Year
$100.37
N/A
Revenue Next Year
$24.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.49
$1.00
52 Week High
$9.05
$2.99

Technical Indicators

Market Signals
Indicator
MAXN
ANL
Relative Strength Index (RSI) 43.50 23.81
Support Level $2.81 $1.32
Resistance Level $3.14 $1.59
Average True Range (ATR) 0.22 0.15
MACD 0.01 -0.03
Stochastic Oscillator 49.53 1.69

Price Performance

Historical Comparison
MAXN
ANL

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: